These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 17360920)
1. Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. Park KH; Hallows JL; Chakrabarty P; Davies P; Vincent I J Neurosci; 2007 Mar; 27(11):2969-78. PubMed ID: 17360920 [TBL] [Abstract][Full Text] [Related]
2. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology. Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549 [TBL] [Abstract][Full Text] [Related]
3. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice. Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886 [TBL] [Abstract][Full Text] [Related]
4. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]
5. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
6. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
8. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. Bloom GS JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463 [TBL] [Abstract][Full Text] [Related]
9. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Janelsins MC; Mastrangelo MA; Park KM; Sudol KL; Narrow WC; Oddo S; LaFerla FM; Callahan LM; Federoff HJ; Bowers WJ Am J Pathol; 2008 Dec; 173(6):1768-82. PubMed ID: 18974297 [TBL] [Abstract][Full Text] [Related]
10. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation. Luan K; Rosales JL; Lee KY Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and amyloid: culprit or coincidence? Skaper SD Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834 [TBL] [Abstract][Full Text] [Related]
12. Mouse models of Alzheimer's disease: the long and filamentous road. Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012 [TBL] [Abstract][Full Text] [Related]
13. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. Xie Y; Tan Y; Zheng Y; Du X; Liu Q J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066 [TBL] [Abstract][Full Text] [Related]
14. [Significance of tau in the development of Alzheimer's disease]. Takashima A Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874 [TBL] [Abstract][Full Text] [Related]
15. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Lee HG; Casadesus G; Zhu X; Castellani RJ; McShea A; Perry G; Petersen RB; Bajic V; Smith MA Neurochem Int; 2009 Feb; 54(2):84-8. PubMed ID: 19114068 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. Green KN; Billings LM; Roozendaal B; McGaugh JL; LaFerla FM J Neurosci; 2006 Aug; 26(35):9047-56. PubMed ID: 16943563 [TBL] [Abstract][Full Text] [Related]
17. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase. Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763 [TBL] [Abstract][Full Text] [Related]
19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]